HomeVSTM • NASDAQ
add
Verastem Inc
Previous close
$12.13
Day range
$11.34 - $12.16
Year range
$4.68 - $15.19
Market cap
291.04M USD
Avg Volume
109.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 28.06M | 45.05% |
Net income | -33.86M | -115.50% |
Net profit margin | — | — |
Earnings per share | -0.98 | 14.22% |
EBITDA | -28.05M | -45.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 110.12M | -0.97% |
Total assets | 123.54M | 2.20% |
Total liabilities | 77.32M | 15.93% |
Total equity | 46.22M | — |
Shares outstanding | 26.83M | — |
Price to book | 13.04 | — |
Return on assets | -51.34% | — |
Return on capital | -62.92% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -33.86M | -115.50% |
Cash from operations | -28.31M | -39.54% |
Cash from investing | 30.98M | 3,953.11% |
Cash from financing | 846.00K | -98.08% |
Net change in cash | 3.52M | -84.68% |
Free cash flow | -19.86M | -38.97% |
About
Verastem Oncology is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia
Founded
2010
Website
Employees
73